RxDoctor Payments Data

Torben Svendsen, DO

Family Medicine · Dayton, TNNPI 1700165081

Payments from drug & device makers

$1,188in general payments, 2019–2025

Across 68 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$198
  • Otsuka America Pharmaceutical, Inc.$194
  • AbbVie$179
  • Novo Nordisk$174
  • GSK$119
  • Amgen$57
  • plus $267 from 9 others

What the payments were for

  • Food & beverage$1,188100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,188 in reported general payments places this provider in the 60th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$4,199
Medicare patients
19
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban246$47,282
NuedextaDextromethorphan Hbr/Quinidine123$44,162
OzempicSemaglutide20$20,486
FarxigaDapagliflozin Propanediol109$15,448
XareltoRivaroxaban29$12,739
MounjaroTirzepatide11$11,798
LinzessLinaclotide16$11,664
MyrbetriqMirabegron75$9,883
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog19$8,529
Spiriva HandihalerTiotropium Bromide12$6,540
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog16$5,589
MovantikNaloxegol Oxalate53$5,378
Novolog FlexpenInsulin Aspart33$5,153
Aripiprazole13$4,971
Divalproex Sodium119$4,428

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$16$47,282246 claims
Novo NordiskOzempic$174$20,48620 claims
Johnson & JohnsonXarelto$26$12,73929 claims
Lilly USA, LLCMounjaro$198$11,79811 claims
AbbVieLinzess$179$11,66416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Dayton

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →